The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2026 | Addressing unmet needs in developing therapies for early onset colorectal cancer
José Perea, MD, PhD, European University of Madrid, Madrid, Spain, comments the current lack of studies on early onset colorectal cancer, particularly in regards to neoadjuvant and adjuvant therapy for this age group, and highlights the need to develop strategies for prospective studies. The current landscape of research will help define approaches to address this gap. This interview took place at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
